Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of a 28-day B.Lactis Consumption Twice Daily on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms. A Proof of Efficacy, Randomized, Controlled, Double-blind, Parallel Arms, Adaptive Design.

NCT05416151 is registered in ClinicalTrials.gov with Danone Global Research & Innovation Center as lead sponsor.

NCT NCT05416151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05416151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of a 28-day B.Lactis Consumption Twice Daily on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms. A Proof of Efficacy, Randomized, Controlled, Double-blind, Parallel Arms, Adaptive Design.
Lead sponsor
Danone Global Research & Innovation Center
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2022
Completion date
April 18, 2024
Enrollment
486 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-intestinal symptoms in healthy subjects